AzTrials
AzTrials

Laryngeal Mask AirwayNCT05832944

Hyomental Distance Measured Ultrasonography Versus Weight-based Criteria for Laryngeal Mask Size Selection in Children

A study testing ultrasound guided hyomental distance in people with Laryngeal Mask Airway, run by Tanta University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In pediatric surgery and emergencies, LMA represents a useful airway management device for routine and difficult airway management. Inserting an improper LMA size may result in malposition, displacement within the hypopharynx, and failed ventilation that needs repositioning. Read more about this study

Who is it for?
Ages 5 to 14 years
Conditions the study is for
Laryngeal Mask Airway
What is being tested?
ultrasound guided hyomental distance
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
Jun 2023to Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Parents' acceptance
  • Age: between 5-14 years
  • Physical Status: American Society of Anesthesiologists (ASA) I \& II)

Who cannot join

  • Developmental Delay (mental and physical growth retardation).
  • Hypersensitivity to any type of used drugs.
  • Patient with a difficult airway ( according to thyromental height and the Mallampati test)
  • Patients with a history of neck surgery
  • Airway malformation.
  • Upper respiratory tract infection.
  • Surgeries that will take up to more than forty-five minutes.

Trial locations and contacts

1 site in 1 country.

SHERIF K ARAFA, MD contact

0580925443

sherifhafez1980@gmail.com

Egypt1 site, 1 recruiting
  • kafrelsheikh university, Faculty of Medicine

    Cairo, 00000

    Sherif k Hafez, MD, 00201004397462, dr_shama2000@yahoo.com

    Recruiting

Other trials in Egypt

About this study

Official title: Hyomental Distance Measured Ultrasonography Versus Weight-based Criteria for Laryngeal Mask Size Selection in Children. A Prospective, Randomised Controlled Study

  • In pediatric surgery and emergencies, LMA represents a useful airway management device for routine and difficult airway management.
  • Inserting an improper LMA size may result in malposition, displacement within the hypopharynx, and failed ventilation that needs repositioning.
  • Selection of the size of LMA represents a major challenge for anesthesiologists, especially in children.
  • The ultrasonographic measured hyomental distance showed a correlation with the length of the pharyngeal cavity.
  • Optimization of the size of the inserted LMA can be confirmed either clinically, ultrasonographic or through the fiberoptic laryngoscope.
  • The ultrasonographic measured hyomental distance confirmed the optimization of LMA with results comparable to that of the clinical methods and better than those of the fiberoptic laryngoscope.
Read the detailed description
  • The laryngeal mask airway (LMA) is classified as one of the supraglottic devices that have been extensively adopted as an adjunctive or alternative technique to tracheal intubation or mask ventilation for airway management in short-time surgery. Moreover, it is characterized by ease of placement and removal, less injury to the respiratory tract, better tolerability by patients, improved hemodynamic stability, less coughing, less sore throat, avoidance of laryngoscopy, and hands-free airway. However, it is not suitable to overcome functional airway problems and mechanical airway obstruction.
  • Although the weight-based method was considered the traditional method for the selection of the optimal LMA size, a clinical practice viewed that this method is not always applicable as there is no linear correlation between the upper airway anatomy and body weight with the presence of usual individual anatomical variation.
  • Fortunately, ultrasonography gave high-resolution images of the anatomic structures of the upper airway comparable to computed tomography and magnetic resonance imaging, Ultrasound measurements were applied for the hyomental distance and the hyomental distance ratio. Some studies revealed variable sensitivity and specificity.
  • This prospective randomized controlled study will aim to assess the efficacy and safety of ultrasonographic measured hyomental distance in the optimization of the laryngeal mask(LMA)size selection and placement in pediatric patients Operational Design
  1. Pre-anaesthetic management:
  • Informed written parental consent will be taken from all participants.
  • Medical history and complete clinical examination.
  • Routine laboratory investigation including :
  1. CBC
  2. CRP
  3. INR, PT \& PTT
  • Patients will fast for at least 8 hours before surgery.
  • Routine Monitoring, including heart rate (HR), oxygen saturation (SpO2) and noninvasive blood pressure (NIBP) in the pre-anaesthesia room (Base Line Data).
  • A peripheral intravenous line (24-22G) will be inserted.
  • A premedication of 0.01 mg/kg Atropine will be administrated IM 1 hour before surgery.
  1. Induction of general anaesthesia:
  • Routine monitoring, including heart rate (HR), oxygen saturation (SpO2), noninvasive blood pressure (NIBP) and continuous electrocardiography (ECG) in the operation room.
  • Intravenous induction of anaesthesia will be performed using Propofol 2 mg/kg, and fentanyl 1µg/kg.
  • Mechanical Ventilation: 6-8 mL/kg Tidal Volume, 10-20 bpm Respiratory Rate, end-tidal CO2 35-40 mmHg and Volume Controlled ventilation with an inspiratory-expiratory ratio of 1:2 will be initiated.
  • For all patients, maintenance of anaesthesia will be performed using Sevoflurane 1-2 %. The depth of anaesthesia will be monitored according to HR.
  1. Process:
  2. Before starting the current study, a pilot experiment has been done, measuring the upper airway parameters of 10 children who used LMA during operation by ultrasound, investigators found that when the hyomental distance was less than 2 cm, 80% of subjects were suited for class 2 LMA and if 2-3 cm, suited for class 2.5 LMA. Additionally, size 3 LMA were fitted to the hyomental distance above 3 cm.
  3. After getting ethical committee approval, and clinical trial registration, 60 pediatric participants will be scheduled for surgery using a laryngeal mask and will be divided randomly into two groups (30 in each group)
Being tested
ultrasound guided hyomental distance
Keywords
hyomental distance, children

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrasound guided hyomental distanceDevice

    measuring the hyomental distance by ultrasound guidance

Study groups in NCT05832944
Study groupRoleWhat they receive
Group HMD (30 patients)Experimentalwhere the size of LMA will be according to measured hyomental distance by ultrasound as follows: * If Less than 2 cm: LMA size 2 will be used. * If 2-3 cm: LMA size 2.5 will be used. * If more than 3 cm: LMA size 3 will be used.
Receives: Device: ultrasound guided hyomental distance
Group CONTROL (30 patients)No interventionwhere size selection will be based on the weight guide

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. correct size selection of LMA

    • A five-point scale will be used to evaluate the ease of LMA insertion from 1 to 5, considering that 1 corresponds to (inserted without resistance) and 5 corresponds to (impossible to insert).

    Measured: During LMA insertion (5 minutes duration)

Secondary outcomes (3)
  1. Values of oropharyngeal leak pressure (OLP) after airway management

    hearing of leakage sounds from LMA

    Measured: During 30 minutes after LMA insertion

  2. postoperative oral injury

    blood adhering to the LMA surface

    Measured: After removal of LMA for 5 minutes

  3. many insertion attempts

    defined as re-insertion after complete LMA removal from the oral cavity

    Measured: During LMA insertion attempts for 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2023
  2. Study startJun 2023 (estimated)
  3. Primary completionNov 2023 (estimated)
  4. Study completionJan 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05832944
Sponsor's protocol ID
MKSU 51-2-18
Status last verified
Apr 2023
First submitted
16 Apr 2023
Last updated
3 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing ultrasound guided hyomental distance in people with Laryngeal Mask Airway, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact AHMED A SHAMA, MD (0580925443, ahmed.shama@med.tanta.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

correct size selection of LMA (time frame: During LMA insertion (5 minutes duration)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in